TSHA vs TYRA Stock Comparison

TYRA currently leads TSHA in this stock comparison, with AIQ scores of 49 vs 35. The clearest difference is quality, while TSHA has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 14 points
TSHA
Healthcare
vs
TYRA
Healthcare
TSHA
Taysha Gene Therapies, Inc.
Price
$4.10
Day move
-2.61%
AIQ Score
35/100
Best edge
Momentum
Sector
Healthcare
TYRA
Tyra Biosciences, Inc.
Leads
Price
$20.03
Day move
+1.32%
AIQ Score
49/100
Best edge
Quality
Sector
Healthcare

What is the main difference between TSHA and TYRA?

TYRA leads the current stock comparison as Tyra Biosciences, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Taysha Gene Therapies, Inc. vs Tyra Biosciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

TYRA leads

TYRA leads by 14 AIQ points, primarily on Quality and Risk Resilience, and the lead has widened from 7 points over 30 sessions.

Competitive: 2 of 4 evidence groups support TYRA, and its lead is widening.

Evidence agreement: 2 of 4Comparison trend: Strengthening
TSHA

Taysha Gene Therapies, Inc.

AIQ Score
35/100
AIQ Edge Score
5/10
TYRA

Tyra Biosciences, Inc.

Leads
AIQ Score
49/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors TYRA over TSHA, 49 versus 35 as of Nov 15, 2026. TYRA's advantage is driven primarily by stronger quality and risk resilience, while TSHA holds the stronger momentum profile. TYRA also shows the stronger technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor TYRA today, and the comparison is rated Competitive on stability: only 2 of 4 covered evidence groups agree. TYRA lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions.

Compare Taysha Gene Therapies, Inc. and Tyra Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

TSHA
-71.5%
TYRA
-25.3%

Price return comparison

Growth of $10,000, price only

TSHA $2,847 · TYRA $7,475

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare TSHA and TYRA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

TSHA advantage
0
TYRA advantage
  • Quality37 vs 75
    TYRA +38
  • Risk Resilience37 vs 45
    TYRA +8
  • Momentum32 vs 27
    TSHA +5

2 of 4 evidence groups favor TYRA. TYRA’s edge is concentrated in quality and risk resilience; TSHA keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

TSHA0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.72x)
TYRA-1 AIQ

Largest factor move: Momentum -3

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

TYRA's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — TSHA and TYRA both carry a full feed there.

The central trade-off

TYRA (Tyra Biosciences, Inc.): the stronger current systematic profile, led by quality and risk resilience.

TSHA (Taysha Gene Therapies, Inc.): the counter-case, on momentum, technicals — but at materially higher volatility, 61.5% against 51.8%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

TYRA

TYRA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

TSHA

TSHA on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

TSHA

TSHA on the Momentum factor, by 5 points.

Lower downside

TYRA

TYRA on Risk Resilience, by 8 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureTSHATYRANote
Implied upside to target—+118.5%Level
Target dispersion—+61.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1315Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 4 covered evidence groups favor TYRA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreTYRA35 vs 49
FundamentalsEvenrevenue growth 0% vs 0%; EPS growth 23.1% vs -7.2%; TTM ROE -11% vs -7.4%
ValuationNot coveredNot covered
TechnicalsTSHAPrice vs 50-day -8.7% vs -7.9%; vs 200-day -22.6% vs -31.9%
Risk ResilienceTYRARisk Resilience 37 vs 45
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TSHA and TYRA and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 14 points. (supports the conclusion holding)
  • Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TYRA.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

TYRA lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions.

May 27TSHA leads above the line · TYRA leads belowNov 13
Today
TYRA +14
35 vs 49
7 sessions ago
TYRA +12
33 vs 45
30 sessions ago
TYRA +7
33 vs 40
90 sessions ago
TSHA +2
52 vs 50

The lead changed hands 6 times in this window, most recently on Oct 12 when TYRA moved ahead of TSHA.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

TSHA

0 bullish / 3 bearish / 2 neutral

No signal that the other name lacks.

TYRA

0 bullish / 5 bearish / 2 neutral

Only TYRA

  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 5 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, ATR Expansion - Breakout Mode, Downtrend Structure Active, Low Volume Rally Warning.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

TSHANo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.61%, AIQ 0 points).

TYRADivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.32%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TSHA closes the Quality gap — currently 38 points behind, the largest single contributor to TYRA's edge.
  2. 2TSHA's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3TYRA starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricTSHATYRA
Revenue growth (YoY)0%0%
EPS growth (YoY)23.1%-7.2%
Gross margin89.2%0%
Operating margin-29.4%0%
Return on equity (TTM)-11%-7.4%
Debt to equity0.150.01

Performance

Split across windows
MetricTSHATYRA
1 week (5 sessions)-5.3%-5.3%
1 month (20 sessions)13.3%8.1%
3 months (63 sessions)-34%-23.6%
6 months (126 sessions)-31.2%-45.9%
Year to date-25.5%-23.8%
1 year (252 sessions)-6%29.4%

Technicals

TSHA has the stronger structure
MetricTSHATYRA
RSI (14)44.742.8
ADX (14)15.112.1
Price vs 50-day-8.7%-7.9%
Price vs 200-day-22.6%-31.9%
Volatility (1M, annualized)61.5%51.8%

Risk

TYRA is the more resilient
MetricTSHATYRA
Beta1.730.53
Sharpe ratio0.320.65
Sortino ratio0.51
Max drawdown-49.7%-53.2%
Current drawdown-41.3%-49.4%
Annualized volatility70.7%67.9%
Value at risk (95%)-6.5%-5.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, TSHA or TYRA?

On the Algovestiq AIQ Score, TYRA is the stronger of the two as of Nov 15, 2026, scoring 49 against TSHA's 35. The edge comes from quality and risk resilience. TSHA is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is TSHA or TYRA the better buy right now?

TYRA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 2 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor TYRA over TSHA?

The composite weights Quality, Value, Momentum and Risk Resilience. TYRA leads Quality by 38 points; TYRA leads Risk Resilience by 8 points; TSHA leads Momentum by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, TSHA or TYRA?

Analyst price targets imply not covered upside for TSHA and +118.5% for TYRA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, TSHA or TYRA?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, TSHA or TYRA?

TSHA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, TSHA or TYRA?

TSHA on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, TSHA or TYRA?

TYRA is the more resilient of the two, so the other name carries the higher downside risk. TYRA on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is TSHA more profitable than TYRA?

TYRA leads on the comparable margin measures — gross margin 89.2% vs 0%; operating margin -29.4% vs 0%; ttm roe -11% vs -7.4%.

Is TYRA's lead over TSHA getting stronger or weaker?

TYRA lead: Strengthening — the AIQ differential moved from 7 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 6 times in that window, most recently on 2026-10-12, when TYRA moved ahead of TSHA.

What would change the TSHA vs TYRA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TSHA closes the Quality gap — currently 38 points behind, the largest single contributor to TYRA's edge; TSHA's Death Cross Active resolves — a bearish trend rule currently active against it; TYRA starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about TSHA and TYRA?

TSHA: 0 bullish / 3 bearish / 2 neutral. TYRA: 0 bullish / 5 bearish / 2 neutral. The most decision-relevant rule on TSHA is Death Cross Active (bearish, long horizon). On TYRA it is Death Cross Active (bearish, long horizon).

Compare TSHA and TYRA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.